Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02393248
Title Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Incyte Corporation
Indications

endometrial cancer

lung squamous cell carcinoma

cholangiocarcinoma

myeloproliferative neoplasm

multiple myeloma

transitional cell carcinoma

breast cancer

Advanced Solid Tumor

stomach cancer

Therapies

Cisplatin + Gemcitabine + Pemigatinib

Docetaxel + Pemigatinib

Pemigatinib + Retifanlimab

Pemigatinib + Trastuzumab

Epacadostat + Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama At Birmingham Comprehensive Cancer Center Birmingham Alabama 35205 United States Details
Cedars-Sinai Medical Center West Hollywood California 90048 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Georgetown University Hospital Washington District of Columbia 20007 United States Details
Hematology Oncology Associates of the Tr Port Saint Lucie Florida 34952 United States Details
Emory University - Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
John Theurer Cancer Center, Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Northwell Health - Monter Cancer Center New Hyde Park New York 11042 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University - Wexner Medical Center Columbus Ohio 43210 United States Details
Signal Point Clinical Research Center Middletown Ohio 45042 United States Details
Greenville Health System Cancer Institute Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Ctr Dallas Texas 75230 United States Details
Md Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Baylor Scott & White Health Temple Texas 76508 United States Details
The Finsen Centre National Hospital Copenhagen 02100 Denmark Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field